In Silico and In Vitro Evaluation of the Mechanism of Action of Three VX809-Based Hybrid Derivatives as Correctors of the F508del CFTR Protein.

MLA

Baroni, Debora, et al. “In Silico and In Vitro Evaluation of the Mechanism of Action of Three VX809-Based Hybrid Derivatives as Correctors of the F508del CFTR Protein.” Pharmaceuticals (14248247), vol. 16, no. 12, Dec. 2023, p. 1702. EBSCOhost, https://doi.org/10.3390/ph16121702.

APA

Baroni, D., Scarano, N., Ludovico, A., Brandas, C., Parodi, A., Lunaccio, D., Fossa, P., Moran, O., Cichero, E., & Millo, E. (2023). In Silico and In Vitro Evaluation of the Mechanism of Action of Three VX809-Based Hybrid Derivatives as Correctors of the F508del CFTR Protein. Pharmaceuticals (14248247), 16(12), 1702. https://doi.org/10.3390/ph16121702

Chicago

Baroni, Debora, Naomi Scarano, Alessandra Ludovico, Chiara Brandas, Alice Parodi, Dario Lunaccio, Paola Fossa, Oscar Moran, Elena Cichero, and Enrico Millo. 2023. “In Silico and In Vitro Evaluation of the Mechanism of Action of Three VX809-Based Hybrid Derivatives as Correctors of the F508del CFTR Protein.” Pharmaceuticals (14248247) 16 (12): 1702. doi:10.3390/ph16121702.